News & Updates

Use of cannabis among Singaporeans usually starts during teenage years, primarily because of peer influence, reveals a study. Later in life, these users may progress to other illicit drugs such as heroin.

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Treatment with dazodalibep, a novel nonantibody fusion protein that acts as an antagonist of CD40 ligand, significantly reduced symptom burden in adults with Sjögren’s syndrome, according to the ALISS trial presented at EULAR 2023.

In the treatment of chronic glucocorticoid users with high fracture risk, romosozumab yields higher gains in spine bone mineral density (BMD) compared with denosumab, as shown in a pilot trial presented at EULAR 2023.

Use of mifepristone in the treatment of patients with adenomyosis appears to be safe and efficacious, reducing pain and inducing dysmenorrhea remission, as reported in a study.